Reduced gray matter volume in cognitively preserved COMT 158Val/Val Parkinson’s disease patients and its association with cognitive decline

The COMT Val158Met polymorphism exerts a common influence on avoidant attachment and inhibited personality, with a pattern of positive heterosis

(2018) Leire Erkoreka et al.   PSYCHIATRY RESEARCH

Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets

(2018) Carles Falcon et al.   NeuroImage-Clinical

Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature

(2017) E. S. Fagan et al.   EUROPEAN JOURNAL OF NEUROLOGY

Correlations between dopamine transporter density measured by 123I-FP-CIT SPECT and regional gray matter volume in Parkinson’s disease

(2017) Tomoko Maekawa et al.   JAPANESE JOURNAL OF RADIOLOGY

Cognitive decline in Parkinson disease

(2017) Dag Aarsland et al.   Nature Reviews Neurology

Natural course of mild cognitive impairment in Parkinson disease

(2017) Kenn Freddy Pedersen et al.   NEUROLOGY

Catechol- O -Methyltransferase gene ( val1 58 met ) polymorphisms and anxious symptoms in early childhood: The roles of hypothalamus-pituitary-adrenal axis reactivity and life stress

(2017) Haroon I. Sheikh et al.   NEUROSCIENCE LETTERS

Correlations between dopamine transporter density measured by 123I-FP-CIT SPECT and regional gray matter volume in Parkinson’s disease

(2017) Tomoko Maekawa et al.   Japanese Journal of Radiology

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

(2017) Chelsea Caspell-Garcia et al.   PLoS One

Prefrontal Volume Mediates Effect ofCOMTPolymorphism on Interference Resolution Capacity in Healthy Male Adults

(2016) Jiayuan Xu et al.   CEREBRAL CORTEX

Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using18F-FP-CIT

(2016) Hongyoon Choi et al.   HUMAN BRAIN MAPPING

The Concept of Prodromal Parkinson’s Disease

(2015) Philipp Mahlknecht et al.   Journal of Parkinsons Disease

Network structure of brain atrophy in de novo Parkinson's disease

(2015) Yashar Zeighami et al.   eLife

Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study

(2014) Cristina Nombela et al.   BRAIN

Measuring mild cognitive impairment in patients with Parkinson's disease

(2013) Connie Marras et al.   MOVEMENT DISORDERS

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Cognitive impairment and dementia in Parkinson's disease

(2012) Javier Pagonabarraga et al.   NEUROBIOLOGY OF DISEASE

Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis

(2012) Angie A. Kehagia et al.   Neurodegenerative Diseases

Health-related quality of life and its determinants in Parkinson’s disease: Results of an Italian cohort study

(2011) Yaroslav Winter et al.   PARKINSONISM & RELATED DISORDERS

The Parkinson Progression Marker Initiative (PPMI)

(2011) Kenneth Marek et al.   PROGRESS IN NEUROBIOLOGY

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

(2009) Caroline H. Williams-Gray et al.   BRAIN

The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease

(2008) J.B. Rowe et al.   NEUROBIOLOGY OF AGING